Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Dickstein

Showing results (101-110 of 372) with videos related to

Pageof 38
Sort By:
Swiss Medical Weekly|August 25, 2018
Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe and in SwitzerlandIvan Zeljkovic, Haran Burri, Alexander Breitenstein, et al.
European Journal of Heart Failure|October 2, 2015
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database InitiativeThomas G von Lueder, Nicolas Girerd, Dan Atar, et al.
Heart (British Cardiac Society)|March 19, 2011
Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarctionIjsbrand T Klip, Adriaan A Voors, Stefan D Anker, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 19, 2023
What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey IIPaolo Gatti, Cecilia Linde, Lina Benson, et al.
European Journal of Heart Failure|November 29, 2012
Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trialMichael S Kiernan, Deborah Wentworth, Gary Francis, et al.
European Heart Journal|April 23, 2009
Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trialStefan D Anker, Adriaan Voors, Darlington Okonko, et al.
Journal of Women'S Health (2002)|January 20, 2022
The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial InfarctionTrygve S Hall, Stein Ørn, Faiez Zannad, et al.
International Journal of Cardiology|August 27, 2018
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunctionTrygve S Hall, Thomas G von Lueder, Faiez Zannad, et al.
European Heart Journal|September 3, 2009
The European cardiac resynchronization therapy surveyKenneth Dickstein, Nigussie Bogale, Silvia Priori, et al.
Journal of the American College of Cardiology|November 16, 2004
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarctionThor Ueland, Rune Jemtland, Kristin Godang, et al.
Pageof 38

Showing results (101-110 of 372) with videos related to

Sort By:
Pageof 38
Swiss Medical Weekly|August 25, 2018
Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe and in SwitzerlandIvan Zeljkovic, Haran Burri, Alexander Breitenstein, et al.
European Journal of Heart Failure|October 2, 2015
Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database InitiativeThomas G von Lueder, Nicolas Girerd, Dan Atar, et al.
Heart (British Cardiac Society)|March 19, 2011
Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarctionIjsbrand T Klip, Adriaan A Voors, Stefan D Anker, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 19, 2023
What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey IIPaolo Gatti, Cecilia Linde, Lina Benson, et al.
European Journal of Heart Failure|November 29, 2012
Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trialMichael S Kiernan, Deborah Wentworth, Gary Francis, et al.
European Heart Journal|April 23, 2009
Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trialStefan D Anker, Adriaan Voors, Darlington Okonko, et al.
Journal of Women'S Health (2002)|January 20, 2022
The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial InfarctionTrygve S Hall, Stein Ørn, Faiez Zannad, et al.
International Journal of Cardiology|August 27, 2018
Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunctionTrygve S Hall, Thomas G von Lueder, Faiez Zannad, et al.
European Heart Journal|September 3, 2009
The European cardiac resynchronization therapy surveyKenneth Dickstein, Nigussie Bogale, Silvia Priori, et al.
Journal of the American College of Cardiology|November 16, 2004
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarctionThor Ueland, Rune Jemtland, Kristin Godang, et al.
Pageof 38